LMMFF yields 40000.00% · JNJ yields 2.13%● Live data
📍 LMMFF pulled ahead of the other in Year 1
Combined, LMMFF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LMMFF + JNJ for your $10,000?
Livium Ltd., together with its subsidiaries, primarily engages in the mineral exploration and technology development activities. It operates through Battery Recycling, Battery Materials, Chemicals, and Raw Materials segments. The company researches and develops processing technologies for mixed-battery recycling, as well as sells recovered energy metals; and researches, develops, and produces battery materials, including lithium ferro phosphate, as well as sells battery energy storage systems. It also researches and develops a suite of extraction and refining technologies for the recovery of lithium chemicals from various materials, including lithium micas and spodumene; and offers end of life solutions for batteries. In addition, the company develops cathode active materials for e-mobility and energy storage applications; and processes lithium chemicals. Lithium Australia Limited was incorporated in 2007 and is based in West Perth, Australia.
Full LMMFF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.